Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit - Schedule of Stock Options Activity (Details)

v3.20.1
Stockholders' Deficit - Schedule of Stock Options Activity (Details) - $ / shares
 9 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Equity [Abstract]    
Number of Shares Outstanding, beginning balance 580,171 354,447
Number of Shares, Granted 15,792 247,896
Number of Shares, Exercised (5,249)
Number of Shares, Forfeited and cancelled (8,718) (18,366)
Number of Shares Outstanding, ending balance 581,996 583,977
Number of Shares Exercisable, ending balance 414,720 266,919
Weighted Average Exercise Price Outstanding, beginning balance $ 11.05 $ 8.30
Weighted Average Exercise Price, Granted 8.87 14.40
Weighted Average Exercise Price, Exercised 4.68
Weighted Average Exercise Price, Forfeited and cancelled 12.56 4.60
Weighted Average Exercise Price Outstanding, ending balance 11.02 11.00
Weighted Average Exercise Price Exercisable, ending balance $ 10.65 $ 9.60
Weighted Average Remaining Contract Term (years) Outstanding, beginning balance 8 years 7 months 2 days 8 years 10 months 14 days
Weighted Average Remaining Contract Term (years) Outstanding, ending balance 7 years 10 months 14 days 8 years 9 months 11 days
Weighted Average Remaining Contract Term (years) Exercisable, ending balance 7 years 6 months 10 days 7 years 11 months 23 days